Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter IDH1 Antikörper (AA 281-414)

Dieses Anti-IDH1-Antikörper ist ein Kaninchen Monoklonal-Antikörper zur Detektion von IDH1 in IHC (f). Geeignet für Human.
Produktnummer ABIN7126537

Kurzübersicht für Rekombinanter IDH1 Antikörper (AA 281-414) (ABIN7126537)

Target

Alle IDH1 Antikörper anzeigen
IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 133
  • 69
  • 48
  • 8
  • 7
  • 7
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 97
  • 57
  • 3
  • 1
Kaninchen

Klonalität

  • 89
  • 69
Monoklonal

Konjugat

  • 100
  • 11
  • 10
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IDH1 Antikörper ist unkonjugiert

Applikation

  • 112
  • 63
  • 36
  • 34
  • 34
  • 30
  • 28
  • 15
  • 13
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 15
    • 14
    • 12
    • 10
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 281-414

    Spezifität

    IDH1 R132H antibody binds to IDH1-mutated protein, but does not bind the wild-type IDH1 protein. IDH1 R132H point mutations are frequently seen in World Health Organization grade II and III gliomas and are believed to constitute an early step in tumorigenesis. IDH1 R132H can be used as a diagnostic marker to help differentiate infiltrating gliomas from gliosis, and as a prognostic marker for gliomas and secondary glioblastoma multiforme. IDH1 R132H antibody shows strong cytoplasmic staining and weaker nuclear staining in tumor cells with the R132H-mutated peptide. Diffuse staining of the fibrillary tumor matrix is also seen.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human IDH1 protein (around aa 281-414) (exact sequence is proprietary)

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HepG2, HeLa, HT29 or MCF7cells. Humanbreast, colon or prostate carcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

    Andere Bezeichnung

    IDH1

    Hintergrund

    Cytosolic NADP-isocitrate dehydrogenase, Epididymis luminal protein 216, Epididymis secretory protein Li 26, HEL-216, HEL-S-26, ICDH, IDCD, IDH1, IDP, IDPC, Isocitrate dehydrogenase 1 (NADP+) soluble, NADP dependent isocitrate dehydrogenase peroxisomal, NADP(+)-specific ICDH, Oxalosuccinate decarboxylase, PICD,IDH1-R132H (Isocitrate Dehydrogenase)
    Cellular localisation: Cytoplasm. Nucleus.

    Molekulargewicht

    45-47kDa

    Gen-ID

    3417, 593422

    UniProt

    O75874

    Pathways

    Warburg Effekt
Sie sind hier:
Chat with us!